foxo4-dri p53 The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 an overview ScienceDirect Topics FOXO4 DRI 10mg (Proxofim) River Peptides Ltd Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $5.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




